Boca Raton, FL -- (SBWIRE) -- 08/28/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners.StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks –Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), ECOtality Inc (NASDAQ:ECTY), Hi-Tech Pharmacal Co. (NASDAQ:HITK),Global Geophysical Services, Inc. (NYSE:GGS)
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) opened the session at $2.26, remained amid the day range of $1.95 - $2.50, and closed the session at $2.01. The stock showed a positive performance of 41.55% in previous trading session. The stock gained a volume of 18.30 million shares and the average volume of the stock remained 1.85million shares. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
For How Long CPRX will Fight for Profitability? Read This Trend Analysis report
ECOtality Inc (NASDAQ:ECTY) traded with volume of 3.27million shares in the prior session and the average volume of the stock remained 1.40 million shares. The 52 week range of the stock remained $0.12 - $2.40. The stock showed a positive movement of 28.83% and closed its session at $0.210. The market capitalization of the stock remained 5.00 Million. Ecotality, Inc. is a provider of electric transportation and storage technologies. The Company provides electric vehicle infrastructure products and solutions that are used in on-road, grid-connected vehicles (including plug-in hybrid electric vehicles (PHEV) and battery electric vehicles).
For How Long ECTY Gloss will Attract Investors? Find out via this report
Hi-Tech Pharmacal Co. (NASDAQ:HITK) exchanged 4.3 million shares and the average volume remained 35,997.00 shares. The stock escalated 22.10% and closed the session at $42.99. The beta of the stock remained +1.30 and the EPS of the stock remained +1.19. The shares outstanding of the stock remained 13.58 million. Hi-Tech Pharmacal Co., Inc. (Hi-Tech), is a specialty manufacturer and marketer of prescription, over-the-counter (OTC) and nutritional products. Hi-Tech develops, manufactures and markets products in three categories: generics, prescription brands and OTC brands.
Will HITK Continue To Move Higher? Find Out Here
Global Geophysical Services, Inc. (NYSE:GGS) gained volume of 626,183 shares, while the average volume remained 260,179.00 shares. The stock advanced 17.78% and finished the session Tuesday at $2.65. The EPS of the stock remained -1.33. The one month of the stock was -36.14% and three month trend remained negative -36.9%. Global Geophysical Services, Inc. (Global), provides an integrated suite of seismic data solutions to the global oil and gas industry, including Global’s RG-3D Reservoir Grade (RG3D) seismic solutions. Its seismic data solutions consists of seismic data acquisition, microseismic monitoring, processing and interpretation services.
Why Should Investors Buy GGS After The Recent Gain? Just Go Here and Find Out
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)